Co-Authors
This is a "connection" page, showing publications co-authored by Takaji Wakita and Masako Yamasaki.
Connection Strength
0.117
-
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. Front Microbiol. 2021; 12:651403.
Score: 0.059
-
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro. Int J Mol Sci. 2021 Mar 19; 22(6).
Score: 0.058